What Medicare’s Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries
(By Juliette Cubanski for The Kaiser Family Foundation published March 9, 2026) The Centers for Medicare & Medicaid Services (CMS)
Read More
GLP-1 drugs
Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford
(Contact – Craig Palosky for The Kaiser Family Foundation published November 14, 2025) About one in eight adults (12%) say
Read MoreWegovy gains new approval: 3 GLP-1 updates
(By: Paige Twenter for Becker’s Hospital Review) Novo Nordisk’s popular weight loss drug, Wegovy, is the first and only GLP-1
Read MoreMedicare will not cover GLP-1s for weight loss: 3 notes
(By: Erica Carbajal for Becker’s Hospital Review) CMS said April 4 it will not move forward with a Biden-era proposal
Read MoreFDA approves GLP-1 generic
(By Paige Twenter for Becker’s Hospital Review) On Dec. 23, the FDA approved Hikma Pharmaceuticals’ liraglutide injection, a generic version
Read MoreFDA adds warning to Ozempic, Mounjaro and other GLP-1 labels
(By Alexandra Murphy for Becker’s Hospital Review) The FDA has updated the labels for all GLP-1 receptor agonists, including popular
Read MoreMedicaid Coverage of and Spending on GLP-1s
(By Elizabeth Williams, Robin Rudowitz, and Clea Bell for The Kaiser Family Foundation Published: Nov 04, 2024) GLP-1 (glucagon-like peptide-1)
Read MoreWeight loss drugs could cost Medicare $6B a year: Study
(By Rylee Wilson for Becker’s Hospital Review) Medicare spending could increase between $3.1 billion and $6.1 billion annually if the
Read MoreMarketplace Insurers are Proposing a 7% Average Premium Hike for 2025 and Pointing to Rising Hospital Prices and GLP-1 Drugs as Key Drivers of Costs
(By Tammie Smith for The Kaiser Family Foundation published August 5, 2024) ACA Marketplace insurers are proposing a median premium
Read MoreWeight loss drugs 1 factor behind ACA premium increases: 3 things to know
(By Rylee Wilson for Becker’s Hospital Review) Premiums for plans on the ACA marketplace will rise 7% on average in
Read More